CDNA(CDNA)
CDNA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $473M | $505M | $554M |
| Low | $472M | $505M | $518M |
| High | $473M | $505M | $591M |
| EBITDA Avg | $-64M | $-68M | $-75M |
| Low | $-64M | $-68M | $-79M |
| High | $-64M | $-68M | $-70M |
| EBIT Avg | $-89M | $-96M | $-105M |
| Low | $-90M | $-96M | $-112M |
| High | $-89M | $-95M | $-98M |
| Net Income Avg | $54M | $69M | $96M |
| Low | $53M | $65M | $91M |
| High | $59M | $73M | $101M |
| EPS Avg | $1.05 | $1.29 | $1.80 |
| Low | $0.99 | $1.22 | $1.70 |
| High | $1.11 | $1.36 | $1.90 |
| Analysts (Rev / EPS) | 5 / 2 | 5 / 3 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $116M | $118M | $120M | $124M | $127M | $133M | $128M | $134M |
| Low | $115M | $117M | $116M | $120M | $124M | $129M | $124M | $131M |
| High | $117M | $118M | $124M | $128M | $132M | $137M | $132M | $139M |
| EBITDA Avg | $-16M | $-16M | $-16M | $-17M | $-17M | $-18M | $-17M | $-18M |
| Low | $-16M | $-16M | $-17M | $-17M | $-18M | $-18M | $-18M | $-19M |
| High | $-16M | $-16M | $-16M | $-16M | $-17M | $-17M | $-17M | $-18M |
| EBIT Avg | $-22M | $-22M | $-23M | $-23M | $-24M | $-25M | $-24M | $-25M |
| Low | $-22M | $-22M | $-23M | $-24M | $-25M | $-26M | $-25M | $-26M |
| High | $-22M | $-22M | $-22M | $-23M | $-23M | $-24M | $-23M | $-25M |
| Net Income Avg | $11M | $11M | $15M | $16M | $18M | $20M | — | — |
| Low | $11M | $11M | $14M | $16M | $17M | $19M | — | — |
| High | $12M | $12M | $15M | $17M | $18M | $21M | — | — |
| EPS Avg | $0.21 | $0.21 | $0.27 | $0.30 | $0.33 | $0.37 | — | — |
| Low | $0.20 | $0.21 | $0.26 | $0.29 | $0.32 | $0.36 | — | — |
| High | $0.22 | $0.22 | $0.28 | $0.32 | $0.34 | $0.39 | — | — |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 2 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |